Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study

被引:3
|
作者
Yue, Rongbin [1 ]
Liu, Xiqiang [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Div Hepatol, Zhuhai, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Hepatic artery infusion chemotherapy; Liver function; Postoperation; POSTOPERATIVE TACE; TUMOR THROMBUS; FAILURE; 5-FLUOROURACIL; PROGNOSIS; MRI; HCC;
D O I
10.1159/000528750
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Liver surgery leads to a high degree of heterogeneity in the prognosis of hepatocellular carcinoma (HCC) patients. However, most previous studies focused on the postoperative therapeutic effects of other treatments, with relatively few studies on the impacts on liver function. This study investigated the impact of transarterial chemoembolization (TACE) and hepatic artery infusion chemotherapy (HAIC) on liver function after HCC resection from various angles. Methods: 138 HCC patients were enrolled, including 27 patients who received TACE and 80 patients who received HAIC. Besides routine treatment such as liver protection and antiviral therapy, 31 patients received no other treatment. The different groups were compared with various biological parameters with four types of scoring methods. Results: In the short term after TACE, the mean (+/- SD) alanine transaminase and aspartate transaminase values increased by 79.22 +/- 117.43 U/L and 66.33 +/- 94.54 U/L, respectively (p < 0.01). The mean (+/- SD) total bilirubin (TBIL) values increased by 4.02 +/- 6.08 mu mol/L (p < 0.01). The mean (+/- SD) albumin (ALB) values decreased by 3.54 +/- 2.93 g/L (p < 0.001). The mean (+/- SD) albumin bilirubin (ALBI) scores increased by 0.39 +/- 0.22 (p < 0.001). In the short term after HAIC, the mean (+/- SD) TBIL values increased by 2.11 +/- 5.57 mu mol/L (p < 0.01). The mean (+/- SD) ALB values decreased by 2.52 +/- 3.26 g/L (p < 0.001), and the mean (+/- SD) ALBI scores increased by 0.21 +/- 0.42 (p < 0.001). In both treatment groups, the long-term liver function was not significantly different from that before treatment and also from that of the untreated group (p > 0.05). Conclusion: TACE after HCC resection has a significant impact on short-term liver function, whereas HAIC has a relatively small impact, but neither has a major impact on long-term liver function.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 50 条
  • [21] Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study
    Fu, Sirui
    Wei, Jingwei
    Zhang, Jie
    Dong, Di
    Song, Jiangdian
    Li, Yong
    Duan, Chongyang
    Zhang, Shuaitong
    Li, Xiaoqun
    Gu, Dongsheng
    Chen, Xudong
    Hao, Xiaohan
    He, Xiaofeng
    Yan, Jianfeng
    Liu, Zhenyu
    Tian, Jie
    Lu, Ligong
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10
  • [22] Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized
    He, Min-Ke
    Le, Yong
    Li, Qi-Jiong
    Yu, Zi-Shan
    Li, Shao-Hua
    Wei, Wei
    Guo, Rong-Ping
    Shi, Ming
    CHINESE JOURNAL OF CANCER, 2017, 36
  • [23] Transarterial Chemoembolization with Additional Cisplatin Infusion for Hepatocellular Carcinoma Invading the Hepatic Vein
    Kim, Hyo-Cheol
    Lee, Jeong-Hoon
    Chung, Jin Wook
    Kang, Beomsik
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    Lee, Hyo-Suk
    Jae, Hwan Jun
    Park, Jae Hyung
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 24 (02) : 274 - 283
  • [24] EXPERIENCE WITH LIVER RESECTION AFTER HEPATIC ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    YU, YQ
    XU, DB
    ZHOU, XD
    LU, JZ
    TANG, ZY
    MACK, P
    CANCER, 1993, 71 (01) : 62 - 65
  • [25] Prophylactic Hepatic Artery Infusion Chemotherapy Improved Survival after Curative Resection in Patients with Hepatocellular Carcinoma
    Huang, San Xiong
    Wu, Yu Lian
    Tang, Cheng Wu
    Feng, Wen Ming
    Xu, Yong Qiang
    Bao, Ying
    Zheng, Yin Yuan
    HEPATO-GASTROENTEROLOGY, 2015, 62 (137) : 122 - 125
  • [26] Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
    Lu, Linbin
    Zheng, Peichan
    Wu, Zhixian
    Chen, Xiong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification
    Jin-Shu Zeng
    Jian-Xing Zeng
    Yao Huang
    Jing-Feng Liu
    Jin-Hua Zeng
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (05) : 482 - 489
  • [28] Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma
    Zhu, Shao-Liang
    Zhong, Jian-Hong
    Ke, Yang
    Ma, Liang
    You, Xue-Mei
    Li, Le-Qun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9630 - 9637
  • [29] Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
    Zheng, Ninggang
    Wei, Xiaodong
    Zhang, Dongzhi
    Chai, Wenxiao
    Che, Ming
    Wang, Jiangye
    Du, Binbin
    MEDICINE, 2016, 95 (26)
  • [30] The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification
    Zeng, Jin-Shu
    Zeng, Jian-Xing
    Huang, Yao
    Liu, Jing-Feng
    Zeng, Jin-Hua
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 482 - 489